Announcements‎ > ‎

2019 TRB Schedule of Selected Workshops, Sessions and Posters

posted Nov 26, 2018, 12:08 PM by Angela Eichelberger   [ updated Nov 26, 2018, 12:19 PM ]

2019 TRB Schedule of Selected Workshops, Sessions and Posters

(ANB50 AOD and Transportation Committee)


Saturday 12th

1:00- 4:00 ICADTS Board Meeting

(Marriott Marquis Hotel, Salon J – Floor M4)


Sunday 13th

Full  day Workshop HF-C: Drug and Alcohol Impairment Challenges for Automated Vehicles (Ticket Required)

(Location TBD)

This workshop addresses designing automated vehicles for interaction with drivers impaired by drugs and alcohol. Explored are the implications of the vehicle taking control from an impaired driver and how to handle takeover requests when the driver is in an impaired state. Participants will gain a better understanding of how different types of drugs affect a driver’s ability to respond, discuss existing evidence, and identify research needs to better inform system design.


Full day Workshop ANB45/Occupant Protection Committee: Moving the Needle: Advancing Infant and Child Occupant Protection (Ticket Required)

(Location TBD)

Although significant progress has been achieved, infant and child motor vehicle occupant safety faces current and newly emerging threats: the rapid growth in ridesharing services, exempt from child restraint laws; gaps in existing laws; impaired drivers who transport improperly seated and restrained children; and continuing issues related to the ease of use, education, nomenclature, and design. Workshop attendees will discuss current and emerging issues, along with evidence-based solutions.


Monday 14th

8:00-9:45 ANB50/The Use of Recent Technology and Treatment in Reducing Impaired Driving Recidivism (Convention Center, 103B)

Recent technological advancements, the development of validated assessment tools, and focused treatment efforts, when used appropriately have shown significant reductions in recidivism for the impaired driving population. This session examines the effects of specific tools and effective treatment programs to reduce recidivism among this population including: the use of validated assessment and screening tools  that adequately identify appropriate measures to monitor and treat impaired driving offenders; the successful implementation of DUI/DWI courts over traditional courts to reduce recidivism of DUI/DWI offenders; the combination of technology and contingency management for DWI offenders; and oral fluid roadside testing in drivers.


10:15-12:00 ANB60 Safe Mobility of Older Persons and ANB50/Legalization of Marijuana and the Safe Mobility of Older Drivers

(Convention center, 103A)

The landscape for legal consumption of marijuana is changing rapidly in the United States. Exactly how these changes are affecting the safe mobility of older persons is not well understood. This session will present an update on the legalization of marijuana across the United States, States recent experience with the legalization process, trends in use by older adults, and other ongoing and upcoming research that has the potential to provide additional insights as to how legalization may impact older driver safety and mobility. A brief panel session will be held after the presentations to discuss the findings to date and to identify topics that need additional research.


1:30-3:15 ANB50/ Impairment on Road Users Other Than Drivers

(Convention center, 101)

Impaired driving is a well-known cause of increased crash involvement and has attracted considerable attention. Most studies focus on drivers and, most of them, consider motorized traffic only. Nevertheless, vulnerable road users may also be of concern and to an even greater extent. Not only may impairment significantly deteriorate their physical condition, but vulnerable road users also present more severe injuries in the event of a collision. This session will examine the effects of alcohol and drugs on non-motorized road users, and will address legislation, data availability, existing evidence, behavior and attitude towards DUI. Particular emphasis will be given to pedestrians and bikers, but other categories will be also discussed.


Tuesday 15th

8:00-12:00 ANB50/AOD and Transportation General Meeting

(Marriott Marquis, Shaw M3)


3:45-5:30 ANB50 Posters

(Convention Center, Hall A)

1.      Factors associated with alcohol-related motor vehicle crash injury and alcohol-related enforcement in the Upstate and Long Island Regions of New York State (19-02215)

2.      A comparison of blood and oral fluid tests for tetrahydrocannabinol (THC) and self-reported marijuana use and test results in drivers: Results from the National Roadside Survey, 2013-2014. (19-04988)

3.      DUI-Child Endangerment: An Analysis of calls made to MADD (19-00427)

4.      Evaluation of Minnesota’s Ignition Interlock Program (19-02894)

5.      An Integrated Spatio-Temporal Approach to Examine the Consequences of Driving under the Influence (DUI) in Crashes (19-00935)

6.      Classification of Fatigued Driving and Drunk Driving Based on Decision Tree Methods: A Simulator Study (19-05937)

7.      Investigating Spatial Spillover Effects in Alcohol-Related Driving Crashes (19-05177)

8.      A Spatiotemporal Bayesian Hierarchical Approach to Analyze Alcohol/Drug Impaired-Driving Related Traffic Crashes by Severity (19-05183)


Wednesday 16th

2:30 PM – 4:00 PM What’s New at the National Highway Traffic Safety Administration: Part I

(Convention Center, Salon B)

·        What is new at NHTSA?

·        Priority Issues and Developments: Autonomous Vehicles and Drug-Impaired Driving

·        NCSA Data & Product Updates

·        Analysis of Recent Trends in Older Drivers Involved in Fatal Crashes

·        National MMUCC Mapping


4:30 PM – 6:00 PM What’s New at the National Highway Traffic Safety Administration: Part II

(Convention Center, Salon B)

·        Behavioral Traffic Safety Cooperative Research Program

·        Roadmap to Improving FARS Drug Data

·        Are Improvements Needed in State Criminal Justice Systems to Adequately Deal with Drug-Impaired Driving?                

·        What Improvements Would Substantially Improve Drug-Impaired Driving Data and the Utility of Toxicological Testing?